Xinxiang Medical University No.1 Affiliated Hospital
Welcome,         Profile    Billing    Logout  
 1 Trial 
22 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Coordinator
NCT05070455: An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Recruiting
4
12
US
Asceniv™
ADMA Biologics, Inc.
Primary Immune Deficiency
03/23
06/23
VRDN-001-302, NCT06179875: An Open-label Study for Participants Who Are Non-responders at the End of Treatment Assessment on the VRDN-001-101 and VRDN-001-301 Pivotal Studies

Recruiting
3
143
Europe, US
Intervention/Treatment
Viridian Therapeutics, Inc.
Thyroid Eye Disease
07/25
03/26
RECOVER, NCT05184335: Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Recruiting
3
402
US
Brilaroxazine, RP5063, Placebo
Reviva Pharmaceuticals
Schizophrenia
10/24
10/24
STRIVE, NCT06384547: A Randomized, Active Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Recruiting
3
212
US
VRDN-001 10 mg/kg, VRDN-001 3 mg/kg
Viridian Therapeutics, Inc.
Thyroid Eye Disease
05/25
01/26
THRIVE-2, NCT06021054: An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants with Chronic Thyroid Eye Disease (TED)

Active, not recruiting
3
188
Europe, US, RoW
Veligrotug (VRDN-001), Placebo
Viridian Therapeutics, Inc.
Thyroid Eye Disease
12/24
09/25
NCT04222062: A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Recruiting
2
100
US
Carmustine 7.7Mg Wafer, GLIADEL
University of Nebraska, Arbor Pharmaceuticals, Inc.
Brain Tumor - Metastatic
12/25
12/26
NCT06107686: A Study of YL202 in Selected Patients With Advanced Solid Tumors

Active, not recruiting
2
200
RoW
YL202 should be intravenously infused
MediLink Therapeutics (Suzhou) Co., Ltd.
NSCLC, Breast Cancer, HNSCC, Locally Advanced or Metastatic Solid Tumors
11/26
11/28
NCT06057922: A Study YL201 in Patients With Selected Advanced Solid Tumors

Recruiting
1/2
640
RoW
YL201 for Injection
MediLink Therapeutics (Suzhou) Co., Ltd.
Advanced Solid Tumor
10/26
10/27
NCT06186596: Self-Administered Intralesional Injections for Acne

Recruiting
N/A
150
US
Triamcinolone delivered via injection assistance device
ACOM Labs
Acne Vulgaris
01/24
01/24
NCT05879198: Train Your Brain: A Pilot Project to Improve Memory and Decision Making

Completed
N/A
24
US
Computer-based Intervention
Henry Ford Health System, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)
Behavior, Health
09/23
09/23
PRIMA-102, NCT05936970: Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD

Recruiting
N/A
830
US
Aqtual, Inc.
Rheumatoid Arthritis
03/25
09/25
NCT04642898: Increasing Treatment Efficacy Using SMART Methods for Personalizing Care

Completed
N/A
66
US
Standard UP Treatment, Capitalization UP Treatment, Compensation UP Treatment
Shannon E. Sauer-Zavala, National Institute of Mental Health (NIMH)
Anxiety Disorders, Post Traumatic Stress Disorder, Obsessive-Compulsive Disorder
06/24
06/24
NCT03594994: Metabolic Effects of Sleep Extension in People With Obesity

Completed
N/A
40
US
Sleep extension
Washington University School of Medicine
Insulin Resistance, Obesity
07/24
07/24
NCT06242704: Train Your Brain 2.0 - Improving Memory and Decision Making Among Youth

Recruiting
N/A
72
US
Working Memory Training, Working Memory
Henry Ford Health System
Behavior, Health
08/26
08/26
NCT04587518: Five Factor Model Treatment for Borderline Personality Disorder

Completed
N/A
100
US
Personality-Based Cognitive Behavioral Therapy
Shannon E. Sauer-Zavala
Borderline Personality Disorder
05/24
05/24
NCT05100836: SURPASS Impella 5.5 Study

Active, not recruiting
N/A
1017
US
Impella 5.5
Abiomed Inc.
Cardiogenic Shock, Acute Decompensated Heart Failure
12/24
12/24
ELEVATE-HF, NCT06592508: Evaluation Of A Virtual Cardiology Program To Improve Outcomes After Acute Decompensated Heart Failure

Recruiting
N/A
180
US
Remote Virtual Cardiology Program
Duke University, Ventricle Health
Heart Failure; With Decompensation
08/26
08/26
NCT03701828: Liver Health and Metabolic Function in People With Obesity

Enrolling by invitation
N/A
30
US
Weight loss surgery, Sleeve gastrectomy, Roux-en-Y, biliopancreatic diversion
Washington University School of Medicine
Non-Alcoholic Fatty Liver Disease
11/24
03/25
PsOWell, NCT05631223: Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)

Recruiting
N/A
87
US
Telemedicine
University of Pennsylvania
Psoriatic Arthritis
02/25
02/25
EIR, NCT05489133: Early Psychological Intervention After Rape

Recruiting
N/A
200
Europe
Modified prolonged exposure, Brief intervention, cognitive behavioral therapy
St. Olavs Hospital, Norwegian University of Science and Technology, The Research Council of Norway, Norwegian Women's Public Health Association (Norske Kvinners Sanitetsforening), National Centre for Emergency Primary Health Care, NORCE, UiT The Arctic University of Norway
Post Traumatic Stress Disorder, Rape Sexual Assault, Sexual Dysfunctions, Psychological, Pelvic Floor Myalgia, Pelvic Pain Syndrome, Depression, Anxiety, Sleep Disturbance, Activity, Motor, Cortisol Deficiency
05/25
12/27
CHOICES3, NCT05292781: Sickle Cell Disease Parenting CHOICES

Recruiting
N/A
506
US
CHOICES, eBook
University of Florida, National Human Genome Research Institute (NHGRI)
Sickle Cell Disease, Sickle Cell Trait
06/25
06/25
EXTEND, NCT05120544: Expanding Technology-Enabled Nurse Delivered Chronic Disease Care

Active, not recruiting
N/A
220
US
EXTEND Plus, EXTEND
Duke University, National Institute of Nursing Research (NINR)
Diabetes Mellitus, Type 2, Hypertension
10/25
10/25

Download Options